When was NeuraStasis founded?

NeuraStasis was founded in 2021.

Where is NeuraStasis located?

NeuraStasis is headquartered in Houston, United States.

How many employees does NeuraStasis have?

As of May 31, 2026, the latest employee count at NeuraStasis is 8.

Is NeuraStasis a funded company?

NeuraStasis is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does NeuraStasis rank among its competitors?

NeuraStasis ranks 27th amongst 46 active competitors, of which 21 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Enspire DBS Therapy, which secured $10.3M in Jan, 2026.

Who are the top competitors of NeuraStasis?

NeuraStasis' top competitors include MicroTransponder, CorTec and Perfuze. Among them, Enspire DBS Therapy secured the most recent funding round in January, 2026.

NeuraStasis - 2026 Company Profile, Team, Funding & Competitors

NeuraStasis' employee count trend

NeuraStasis has 8 employees as of May 26. Here is NeuraStasis's employee count trend over the years:

Uncover NeuraStasis' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of NeuraStasis include MicroTransponder, CorTec and Perfuze. Here is the list of Top 10 competitors of NeuraStasis, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	MicroTransponder 2007, Dallas (United States), Series F	Developer of neuromodulation therapy for neurological conditions	$180M	USVP, Green Park & Golf Ventures & 11 others	63/100
2nd	CorTec 2010, Freiburg im Breisgau (Germany), Series C	Manufacturer of active implantable neurotechnology devices, components, and sub-assemblies	$21.6M	Santo Venture Capital, K & SW Consult & 7 others	61/100
3rd	Perfuze 2018, Galway (Ireland), Series A	Developer of a medical device for the treatment of acute ischemic stroke	$53.2M	Earlybird, Seroba Lifesciences & 7 others	61/100
4th	NeuroLutions 2007, St. Louis (United States), Series A	Developer of robotic glove controlled by brain	$28.3M	Ascension Ventures, Prolog Ventures & 6 others	61/100
5th	Conformal Medical 2016, Nashua (United States), Series D	Innovating stroke prevention with minimally invasive Left Atrial Appendage Occlusion	$161M	CHV, Sprig Equity & 4 others	58/100
6th	Enspire DBS Therapy 2010, Chagrin Falls (United States), Series B	Developer of stroke recovery therapy	$27.9M	Cleveland Clinic, Genesys Capital & 3 others	51/100
7th	MIVI Neuroscience 2013, Eden Prairie (United States), Series C	Developer of catheters for acute ischemic stroke therapy	$66.5M	Concord Health Partners, Deerfield & 2 others	50/100
8th	BrainQ 2011, Jerusalem (Israel), Series B	Developer of AI-powered electromagnetic stimulation technology for stroke disability recovery	$48.8M	Hanaco Ventures, OurCrowd & 8 others	45/100
9th	BeAble Health 2017, Hyderabad (India), Seed	Developer of upper limb rehabilitation device	$35K	Villgro, Social Alpha & 1 others	44/100
10th	IRegained 2016, Greater Sudbury (Canada), Seed	Developer of therapeutic solutions for treating stroke or traumatic brain injury	$779K	Northern Ontario Angels, Norcat & 2 others	40/100
27th	NeuraStasis 2021, Houston (United States), Funding Raised	Developer of medical device for brain tissue	-	MedTech Innovator, Berkeley SkyDeck	28/100